Yuan-Zhen Chen (Yuanzhen Chen)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 7

Top Topics

Ejection Fraction

Spinal Cord Injury

Lipopolysaccharide Induced

Chronic Kidney Disease

Top Venues

Disease markers

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Haojun Shi, Liangyu Xie, Wenchang Xu, Sheng-Nan Cao, Yuan-Zhen Chen
Nogo-A Is a Potential Prognostic Marker for Spinal Cord Injury. Disease markers 2022 (2022)
Sheng-Nan Cao, Guangjian Hou, Ya Meng, Yuan-Zhen Chen, Liangyu Xie, Bin Shi
Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury. Disease markers 2022 (2022)
Fan-Jie Liu, Hong-Hao Xu, Ying Yin, Yuan-Zhen Chen, Liang-Yu Xie, Hua-Zhong Li, Dan-Dan Wang, Bin Shi
Decreased Adiponectin Levels Are a Risk Factor for Cognitive Decline in Spinal Cord Injury. Disease markers 2022 (2022)
Xiaoxun Du, Xiaoying Wang, Kaiying Cui, Yungang Chen, Chao Zhang, Kang Yao, Yanke Hao, Yuan-Zhen Chen
Tanshinone IIA and Astragaloside IV Inhibit miR-223/JAK2/STAT1 Signalling Pathway to Alleviate Lipopolysaccharide-Induced Damage in Nucleus Pulposus Cells. Disease markers 2021 (2021)
Fan-Jie Liu, Liang-Yu Xie, Hua-Zhong Li, Sheng-Nan Cao, Yuan-Zhen Chen, Bin Shi, Dan-Dan Wang
Expression of ANGPTL4 in Nucleus Pulposus Tissues Is Associated with Intervertebral Disc Degeneration. Disease markers 2021 (2021)
Hong Ma, Fengshan Lu, Yueming Guo, Zhaoxiong Shen, Yuan-Zhen Chen
The Prognostic Value of Leucine-Rich α2 Glycoprotein 1 in Pediatric Spinal Cord Injury. BioMed research international 2021 (2021)
Shifei Sun, Shilong Sun, Yan Meng, Bin Shi, Yuan-Zhen Chen
Elevated Serum Neuropeptide FF Levels Are Associated with Cognitive Decline in Patients with Spinal Cord Injury. Disease markers 2021 (2021)